Diabetes Discourse

The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results and implications for clinical care.

The developing artificial pancreas carries tremendous potential for the treatment of diabetes. What is research telling us about the various steps to the implementation of the system? Join host Dr. Steven Edelman and his guest, pediatric endocrinologist and professor of medicine at Stanford University, Dr. Bruce Buckingham, as they discuss design, function, implementation, and obstacles to developing the artificial pancreas.

The ACT NOW study examined whether treatment of impaired glucose tolerance in pre-diabetic patients with pioglitazone could prevent or delay the development of type 2 diabetes. Join host Dr. Steven Edelman and his guest, endocrinologist and professor of medicine at the University of California San Diego, Dr. Robert Henry, as they discuss the results and implications for clinical care.

The developing artificial pancreas carries tremendous potential for the treatment of diabetes. What is research telling us about the various steps to the implementation of the system? Join host Dr. Steven Edelman and his guest, pediatric endocrinologist and professor of medicine at Stanford University, Dr. Bruce Buckingham, as they discuss design, function, implementation, and obstacles to developing the artificial pancreas.

The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

The ACCORD, ADVANCE and VA Diabetes Trials seem to indicate that there is no real benefit of intensive glycemic control on cardiovascular events in patients with type 2 diabetes. Join host Dr. Steven Edelman and his guest, executive director of the International Diabetes Center at Park Nicollet, Dr. Richard Bergenstal, as they discuss the implications on clinical care and benefits of glycemic control.

World Diabetes Day marks the annual global awareness campaign for diabetes by the International Diabetes Federation. The campaign’s theme of "diabetes education and prevention" is scheduled for five years. How will the IDF implement this broad campaign for both the health care professionals and people living with diabetes? Join host Dr. Steven Edelman and his guest, vice president of the International Diabetes Federation, Anne-Marie Felton, as they discuss World Diabetes Day and the need for diabetes education and prevention.

Pharmacogenomics is applied to select medications with the goal of optimizing drug therapy: maximizing efficacy, minimizing toxicity, and minimizing pharmacokinetic and pharmacodynamic variability. Join guest host, Dr. Candis Morello and Dr. Joseph Ma, assistant professor of clinical pharmacy at the University of San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, as they discuss the impact of pharmacogenomics in diabetes therapy.

The new class of medications known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which stimulate the pancreas to make more insulin after eating a meal, may be changing the way we treat people with type 2 diabetes. Join guest host, Dr. Candis Morello and her guest, professor of clinical pharmacy in the School of Pharmacy at the University of California San Francisco, Dr. Lisa Kroon, as they discuss the use of DPP-4 therapy in the treatment of type 2 diabetes.

The results of the landmark Diabetes Control and Complications Trial proved that intensive management of diabetes can significantly improve diabetes outcomes. The education of both the healthcare professional and patient is a key component in the successful management of diabetes. Join host Dr. Steven Edelman and his guest, executive director of Taking Control of Your Diabetes (TCOYD), Sandra Bourdette, as they discuss the mission and results of their novel approach to diabetes education.